Akums Launches Oral Suspension of Hydroxyurea Effective in the Treatment of Sickle Cell Disease and Driving the Oral Syringes Market
Akums Drugs and Pharmaceuticals announced the launch of an oral suspension that is stable at room temperature and received regulatory approval from the Drug Controller General of India. This formulation of hydroxyurea does not need any cold storage and it is an easily accessible and readily available product to treat sickle cell diseased patients. With […]